
Quantum Innovation Catalyzer Program
Empowering Breakthroughs in Healthcare Innovation
The Cleveland Clinic Quantum Innovation Catalyzer Program provides an opportunity for early- and venture stage companies to explore quantum computing applications in healthcare and life sciences. The 12-month immersive experience includes dedicated access to IBM’s Quantum System One at Cleveland Clinic’s main campus, the first quantum computer dedicated to healthcare and life sciences research.
The program will select up to four companies through a competitive application process.
The winning companies will have an opportunity to receive an investment of up to $250,000 from K5 Tokyo Black Fund with an in-kind match from Cleveland Clinic.
Applications are open August 18 through October 31. Teams will be selected in December 2025. The program will begin in March 2026.
The program includes:
- Access to IBM Quantum System
- Operating space on Cleveland Clinic’s main campus
- Opportunities to explore research ideas and projects
- Educational offerings
- Advanced business networking
Apply now or contact ComputationalLifeSci@ccf.org with any questions.
2024 Quantum Innovation Catalyzer Program Accomplishments
The inaugural class of Cleveland Clinic’s Quantum Innovation Catalyzer Program included Ohio-based Qradle and Finland-based Algorithmiq. Both organizations collaborated with Cleveland Clinic on groundbreaking research with quantum technologies.
Algorithmiq
Algorithmiq led a project in collaboration with Cleveland Clinic and IBM Quantum to create a set of computational tools that aims to explore how quantum computing could assist in the development of photon-activated drugs for cancer. The project won the first phase of Wellcome Leap’s Quantum for Bio Challenge, a global challenge that focuses on accelerating the development of quantum computing applications for healthcare.
Qradle
Qiang Guan, PhD, from Qradle Inc., collaborated with Feixiong Cheng, PhD, Cleveland Clinic to publish a paper in arXiv on their work using a quantum computer to predict protein folding structures. Their results have outperformed the accuracy of AlphaFold 3.

About the Discovery Accelerator
The Discovery Accelerator is a 10-year partnership between Cleveland Clinic and IBM aimed at advancing biomedical research through pioneering applications of quantum and advanced computing. As part of this partnership, IBM Quantum System One, the first private sector, on-site quantum computer was constructed in the Lerner Research Institute.
The partnership is the technological foundation of biomedical research occurring as part of the Cleveland Innovation District. The district brings the State of Ohio and JobsOhio together with Cleveland’s healthcare and higher education institutions to create jobs, accelerate research and educate the workforce of the future.
For questions or feedback, please contact:
- Kosta Mathiellis, Executive Director – Strategic Operations
- Todd Schwarzinger, Partner – Cleveland Clinic Ventures